To improve outcomes during the COVID-19 pandemic and beyond, organizations are using real-world data for efficient and effective decision-making. At a time like this, researchers and leaders have to look beyond time-intensive, expensive randomized controlled trials. In order to find the answers to a question that is always evolving, the industry will need to examine information that is similarly ever-changing: Real-world data.
Defined by the FDA as data relating to patient health status or the delivery of healthcare routinely collected from a range of sources, real-world data is increasingly being used in clinical decision-making. Organizations are leveraging EHR data, patient registries, and mobile device information to better understand trends and outcomes, leading to improved care delivery. Read more here.
(Source: Jessica Kent; Health IT Analytics; 1/4/2021)
